Avm Biotechnology Inc
Clinical trials sponsored by Avm Biotechnology Inc, explained in plain language.
-
New drug aims to control blood cancers in early trial
Disease control Recruiting nowThis study tests a new drug called AVM0703 in people with certain blood cancers (lymphoid malignancies). The goal is to see if it is safe and can shrink tumors. About 144 people aged 12 and older will receive a single infusion of the drug. The study is currently recruiting.
Phase: PHASE1, PHASE2 • Sponsor: AVM Biotechnology Inc • Aim: Disease control
Last updated May 17, 2026 04:01 UTC
-
New drug available for cancer patients through expanded access program
Disease control AVAILABLEThis program provides an experimental drug called AVM0703 to people with various cancers, including brain tumors, breast cancer, and leukemia. It is available in the US when a doctor requests it. So far, 37 patients have received the treatment, and side effects have been mostly m…
Sponsor: AVM Biotechnology Inc • Aim: Disease control
Last updated May 17, 2026 03:58 UTC